Efficacy of iPACK After Unilateral TKA
Arthroplasty Complications, Pain, Joint, Arthritis Knee
About this trial
This is an interventional prevention trial for Arthroplasty Complications focused on measuring Knee arthroplasty, Pain control, iPACK, Local infiltration analgesia, Early rehabilitation
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologist (ASA) physical status score I-III
- Scheduled for elective unilateral TKA
- Age > 18 < 80 years
- BMI < 40 kg/m2
Exclusion Criteria:
- American Society of Anesthesiologist (ASA) physical status score (ASA) IV
- Patient scheduled for revision of TKA
- Rheumatoid Arthritis patient
- Prior back surgery
- Patients on any anticoagulant
- Any other contra-indication for spinal anesthesia
Sites / Locations
- King Khalid University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
iPACK
Periarticular local infiltration analgesia (LIA)
In this group, participants will receive a peripheral nerve anesthetic block that is iPACK (Interspace between the Popliteal Artery and the Capsule of the posterior Knee) to cover posterior knee pain after total knee arthroplasty (TKA). This anesthetic block will be performed by assigned anesthesiologist under ultrasound guidance.
In this group, participants will receive a mixture of bupivacaine 0.25% 20 ml + epinephrine 100 mics ± lornoxicam 8 mg ± morphine 10 mg ± tranexamic acid 1 gm in 40 ml normal saline (NS) that will be injected into the posterior capsule and the medial and lateral ligaments just before implantation: after insertion of the implants and into the capsule and retinacular tissues. The remaining solution (approximately 20 mL) will be used to infiltrate the muscle and subcutaneous tissues. This local anesthetic infiltration is commonly performed by the operating orthopedic surgeon during TKA for postoperative pain control.